N. Inanc < N. Ishiguro < N. Iwamoto

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000451 (2013)	T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; N. Asai [Japon] ; N. Ishiguro [Japon]	SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis
000540 (2013)	N. Asai ; T. Kobayakawa ; K. Saito ; T. Shioura ; Y. Yabe [Japon] ; T. Kojima ; A. Kaneko [Japon] ; N. Ishiguro	AB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry
000556 (2013)	Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. Ishiguro	SAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
000561 (2013)	N. Takahashi [Japon] ; T. Kojima [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; H. Matsubara [Japon] ; Y. Hattori [Japon] ; N. Ishiguro [Japon]	AB0563 Impact of the history and the type of previous biologic treatment on abatacept efficacy in rheumatoid arthritis patients
000567 (2013)	Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. Ishiguro	AB0338 Evaluation of tocilizumab treatment continuation rate stratified by time of start of administration
000571 (2013)	Y. Kanayama ; T. Kojima ; Y. Hirano ; N. Takahashi ; K. Funahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; Y. Oishi ; N. Ishiguro	AB0585 Radiographic progression of cervical lesions and hands in patients with rheumatoid arthritis receiving tocilizumab treatment from japanese tbc registry
000572 (2013)	Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; T. Shioura ; N. Asai ; T. Kobayakawa ; K. Saito [Japon] ; N. Ishiguro	AB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry
000582 (2013)	Y. Kanayama ; T. Kojima ; Y. Hirano ; Y. Yabe [Japon] ; N. Takahashi ; K. Funahashi ; Y. Oishi ; N. Ishiguro	AB0336 Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving tocilizumab treatment comparison with infliximab treatment from japanese tbcr
000615 (2013)	H. Ishikawa [Japon] ; A. Kaneko ; D. Kida ; T. Sato ; T. Kojima [Japon] ; N. Ishiguro [Japon]	AB0534 Efficacy and safety to use halfdose abatacept therapy between 24weeks in patients with rheumatoid arthritis in japanese
000639 (2013)	A. Kaneko ; N. Takahashi ; D. Kida ; Y. Hirano [Japon] ; H. Ishikawa ; T. Kojima ; N. Ishiguro	AB0515 Predictors of clinical remission (DAS28CRP<2.6) in patients with RA who were treated with abatacept
000657 (2013)	Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. Ishiguro	AB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy
000763 (2013)	H. Yamanaka ; M. Harigai ; S. Inokuma [Japon] ; N. Ishiguro ; J. Ryu [Japon] ; S. Takei ; T. Takeuchi [Japon] ; Y. Tanaka ; Y. Sano [Japon] ; T. Koike [Japon]	THU0092 The advantage of early intervention by tocilizumab for rheumatoid arthritis - full analysis of all-case postmarketing surveillance in 7,901 patients in japan
000852 (2013)	T. Kojima ; K. Funahashi ; N. Takahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; N. Ishiguro	THU0124 Importance of monitoring of C-reactive protein level to predict achievement of better clinical outcome during treatment with tocilizumab in patients with rheumatoid arthritis
000937 (2013)	Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. Ishiguro	AB0339 A retrospective study on rapidness of efficacy in abatacept terapy in patients with rheumatoid arthritis from japanese multicenter registry system
000987 (2013)	S. Hirabara [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; M. Hanabayashi [Japon] ; K. Terabe [Japon] ; Y. Yoshioka [Japon] ; N. Ishiguro [Japon]	SAT0134 Clinical Efficacy of Abatacept in Rheumatoid Arthritis Patients with Prior Use of Tocilizumab; Results from Japanese Multicenter Registry System TBCR
000999 (2013)	M. Harigai ; S. Inokuma [Japon] ; N. Ishiguro ; J. Ryu ; T. Takeuchi [Japon] ; S. Takei ; Y. Tanaka ; H. Yamanaka ; Y. Sano [Japon] ; H. Yaguramaki [Japon] ; T. Koike [Japon]	SAT0120 Characteristics Associated with Better Effectiveness and Safety in Rheumatoid Arthritis Patients Treated with Intravenous Tocilizumab: Results from Full Analysis of All-Patient Postmarketing Surveillance in Japan
000B74 (2013)	H. Ishikawa ; Y. Hirano ; A. Kaneko ; D. Kida ; T. Sato ; T. Kojima ; T. Kanamono [Japon] ; N. Ishiguro	SAT0093 Pregnancy in patients with rheumatoid arthritis treated witn biological agents: Results of the 8-year of japanese tbc registry
000C06 (2013)	Y. Tanaka ; M. Harigai ; T. Takeuchi ; H. Yamanaka [Japon] ; N. Ishiguro ; K. Yamamoto [Japon] ; M. Kanazawa ; Y. Murakami ; T. Yoshinari [Japon] ; D. Baker [États-Unis] ; N. Miyasaka ; T. Koike [Japon]	FRI0177 52-week results of clinical, radiographic and pharmacokinetic assessments: Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy
000C84 (2013)	Y. Tanaka ; K. Yamamoto [Japon] ; T. Takeuchi ; H. Yamanaka [Japon] ; N. Ishiguro ; K. Eguchi ; A. Watanabe [Japon] ; H. Origasa ; T. Okamoto ; T. Shoji ; N. Miyasaka [Japon] ; T. Koike [Japon]	AB0294 Long-term comprehensive disease control with certolizumab pegol regardless of concomitant dmards: results from the japanese cohort
000D50 (2013)	S. Asai [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Katoh [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; K. Terabe [Japon] ; N. Ishiguro [Japon]	SAT0013 Risk Factors for Progression of Large Joint Destruction in Patients with Rheumatoid Arthritis Based on Incident Rate of Joint Surgery During Treatment with Biologics
000D73 (2013)	M. Hanabayashi [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; N. Ishiguro [Japon]	SAT0118 The Clinical Outcome of Abatacept Treatment in Biologic NaÏVe Patients with Rheumatoid Arthritis in Multi-Center Clinical Practice

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/Author.i -k "N. Ishiguro" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/Author.i  \
                -Sk "N. Ishiguro" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    N. Ishiguro
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021